Navigation Links
Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
Date:10/8/2007

PETALUMA, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) announced today that the company will be presenting at the 4th Annual BIO InvestorForum Conference to be held October 9-11, 2007 at the Palace Hotel of San Francisco. The company's president and chief executive officer, Hoji Alimi, is scheduled to present an overview of the company, its clinical programs and the most recent quarter on Thursday, October 11 at 1:30 p.m. PDT (4:30 p.m. EDT) in the Sea Cliff room. For more information on this event please visit: http://www.investorforum.bio.org/.

To access a live audio and visual webcast of Mr. Alimi's presentation, please log on to Oculus Innovative Sciences' website at http://ir.oculusis.com/events.cfm approximately 30 minutes prior to the presentation in order to register and download any necessary software. The webcast will be available for 30 days at this website.

About Oculus

Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn(R) Technology platform, which is intended to help prevent and treat infections in chronic and acute wounds. The Microcyn Technology platform is a controlled slow-release solution containing active chlorine and other gases resulting in a biocompatible technology to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria, viruses, fungi and spores. The technology has demonstrated significant wound healing in chronic and acute wounds. It has been commercialized outside of the U.S. for the trea
'/>"/>

SOURCE Oculus Innovative Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference
2. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
3. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
4. DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
9. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
10. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
11. Answerthink and LORENZ Life Sciences Group Announce Strategic Alliance for the SAP Life Science Industry

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., HARBIN, China, Nov. 25 /PRNewswire-Asia-F...ky One Medical" or "the Company") (Nasdaq: CSKI )...y developing and producing,over-the-counter drugs ...nnounced that the Company recently passed the Chin...utical and Biological Products ("ICPBP") examinati...
(Date:11/25/2009)..., EAST BRUNSWICK, N.J., Nov. 25 S... of direct digital Radiography ( ddR ) systems, an...ed by a private Swiss Investor with a long term vi...d. The acquisition included all assets and intelle.... After 25 years of success and growth Swissray is...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, Pain Manag...nker.com/p0164220/Pain-Management---Global-Trends....gs, emergence of pain management clinics, and the ...rowth in the pain management market. Healthcare re...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 1Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 2Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 3Herbicide diversity needed to keep Roundup effective 9243 1Herbicide diversity needed to keep Roundup effective 9243 2Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 1Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 2
...d Community Oncology Research Network, Inc. Surpas...MEMPHIS, Tenn., March 31 The Accelerated Communit...nal oncology clinical trial,network, announced tod...xceeded performance expectations over the past 12 ...earch services to sponsors, from clinical,trial de...
... of Target Enrollment Expected in Fourth Quarter, ...ted (Nasdaq: GNTA ) announced that the Data Safet...ial of Genasense (oblimersen sodium),Injection, wh...commended,that the trial be continued as originall...ata from the study., AGENDA is a Phase 3, randomi...
Other Medicine Technology:ACORN's Oncology-focused Contract Research Organization Exceeds Projections 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 4
(Date:11/29/2009)... "The YogaForce A-Line Athletic Mat is grea... Weil, M.D., author and physician best known for e...ive medicine. Go to www.yogaforce.com and order...ift list. , San Francisco... the holidays, the YogaForce newly patented, revol...
(Date:11/28/2009)...Nov. 28 Get ready for advanced ...nical routine when Siemens introduces syngo...nnual Meeting of the Radiological Society of North...McCormick Place (Booth #825, East Building/Lakesid... , Siemens, new imaging software for multimodal...
(Date:11/28/2009)...elp lift spirits, recognize signs of depression ,...For many seniors, the holiday season can trigger m...uggle with health issues or worry about money prob.... , To help overcome the seasonal blues, the AG...ing advice: , Get out and socialize or invite fa...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued its la...c data. It shows that the lethality of the virus ... the virus,s current outbreak in the spring of 200...(s.d. 0.1). The H1N1 infectivity count, however, r...n (PRWEB) November 27, 2009 -- Biotech firm Replik...
(Date:11/27/2009)...N.Y., Nov. 27 Preventin...r and fortunately every year, new vaccines are bei...ll vaccines boost immunity for the same period of ...ots, needed to keep immunity strong? ,, In th... American Academy of Pediatrics, Michael Pichicher...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
...nsion journal suggests that increasing, dietary ...revention of hypertension, a major pu...e good sources of potassium and low in sodium ...Hypertension,concludes that an increase in potassi...
...olecular "smart bombs" to target metastasis with a...ficantly lower doses of toxic chemotherapy, with l...ding to a collaborative team of researchers at the...ector of Translational Research David Cheresh, Ph....
...ty HealthSystem,Consortium (UHC), welcomes Susan K...Chief Learning Officer. Dr. Pingleton has more tha...cine and comes to UHC from The,University of Kansa... Scholar in Residence at the Association of,Americ...
...sk for psychiatric disorders, study finds , ...lone isn,t associated with an increased risk of me...en suggested that pregnant women and those who,ve ...he study. , To determine whether this was true, th...
... trusted and,accessible health care providers, pha... and make more than 80 million recommendations to ...tients will follow these,recommendations. In fact,... purchase a particular OTC medicine based on,their...
...ny,(Nasdaq: PRGO ;TASE) announced today that Jose...t at the Oppenheimer & Co. Inc. 8th Annual Consume...m. (ET) at the Four Seasons,Hotel in Boston. The p...l healthcare supplier that develops,manufactures a...
Other Medicine News:Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 2Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 3Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 4Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 5Health News:'Smart bomb' nanoparticle strategy impacts metastasis 2Health News:University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer 2Health News:Pregnancy Alone Not A Risk for Mental Health Problems 2
SureStep LH
Clearview Exact Strep A Dipstick
Clearview Exact Strep A Cassette
Inverness Medical Testpack+Plus Strep A with OBC (20 Tests)
Medicine Products: